FTSE All-Share
5.020,83
PKT
+2,62
PKT
+0,05
%
Werbung
Analysen zu FTSE All-Share-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 21.02.24 | Glencore Buy | UBS AG | |
| 21.02.24 | Rio Tinto Overweight | JP Morgan Chase & Co. | |
| 21.02.24 | Rio Tinto Neutral | UBS AG | |
| 21.02.24 | Rio Tinto Sector Perform | RBC Capital Markets | |
| 21.02.24 | HSBC Sector Perform | RBC Capital Markets | |
| 21.02.24 | GSK Buy | Deutsche Bank AG | |
| 21.02.24 | HSBC Buy | Jefferies & Company Inc. | |
| 21.02.24 | HSBC Neutral | UBS AG | |
| 21.02.24 | HSBC Neutral | JP Morgan Chase & Co. | |
| 20.02.24 | AstraZeneca Sell | Deutsche Bank AG | |
| 20.02.24 | BP Underweight | JP Morgan Chase & Co. | |
| 20.02.24 | Shell (ex Royal Dutch Shell) Overweight | JP Morgan Chase & Co. | |
| 20.02.24 | AstraZeneca Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 19.02.24 | HSBC Neutral | JP Morgan Chase & Co. | |
| 19.02.24 | BAT Overweight | Barclays Capital | |
| 19.02.24 | Unilever Overweight | Barclays Capital | |
| 19.02.24 | AstraZeneca Sell | UBS AG | |
| 19.02.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 19.02.24 | Shell (ex Royal Dutch Shell) Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 19.02.24 | BAT Buy | Jefferies & Company Inc. | |
| 16.02.24 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 16.02.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 15.02.24 | BAT Buy | Deutsche Bank AG | |
| 15.02.24 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets | |
| 15.02.24 | GSK Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 14.02.24 | BP Buy | UBS AG | |
| 14.02.24 | Unilever Sell | UBS AG | |
| 14.02.24 | Unilever Halten | DZ BANK | |
| 13.02.24 | Unilever Neutral | Goldman Sachs Group Inc. | |
| 13.02.24 | BAT Neutral | UBS AG | |
| 13.02.24 | Glencore Outperform | RBC Capital Markets | |
| 13.02.24 | Rio Tinto Overweight | JP Morgan Chase & Co. | |
| 12.02.24 | AstraZeneca Halten | DZ BANK | |
| 12.02.24 | Unilever Market-Perform | Bernstein Research | |
| 12.02.24 | Diageo Sell | Deutsche Bank AG | |
| 12.02.24 | BAT Neutral | JP Morgan Chase & Co. | |
| 12.02.24 | BP Outperform | RBC Capital Markets | |
| 12.02.24 | BAT Neutral | Goldman Sachs Group Inc. | |
| 12.02.24 | AstraZeneca Overweight | Barclays Capital | |
| 09.02.24 | GSK Buy | UBS AG |